These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3842058)

  • 1. [Comparative evaluation of the protective effect of broxaterol and salbutamol in bronchial spasm induced with an ultrasonic aerosol of distilled water].
    De Francesca F; Grembiale RD; Bova G; Pelaia G; Tranfa CM; Marsico SA
    Arch Monaldi; 1985; 40(3-4):111-22. PubMed ID: 3842058
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protective action of broxaterol in bronchial spasm induced by ultrasonic mist].
    Aversa C; Scorrano F; Scoditti S; Pancosta G; Stomeo S
    Arch Monaldi Mal Torace; 1988; 43(3):243-8. PubMed ID: 2908378
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of a new beta 2-agonist (broxaterol) on bronchospasm induced by methacholine (blind study versus salbutamol)].
    Corrias A; Corona GB; Pelosi U; Corda R
    Pediatr Med Chir; 1989; 11(1):61-3. PubMed ID: 2566160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the effectiveness and tolerance of a new beta-2 stimulant (broxaterol) vs. salbutamol in patients with chronic obstructive bronchopneumopathy].
    Giosuè S; Guerrini P; Cafaggi R; D'Onofrio V; Perrone N; Scano M
    Clin Ter; 1987 Apr; 121(1):35-9. PubMed ID: 2885123
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of broxaterol in bronchial hyperresponsiveness.
    Bianco S
    Respiration; 1989; 55 Suppl 2():20-7. PubMed ID: 2572037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protective effects of nifedipine, DSCG and salbutamol in bronchospasm induced by ultrasonic mist].
    Mazzarella G; Cammarata A; Nardi S; Grella E
    Arch Monaldi Mal Torace; 1987; 42(2):183-90. PubMed ID: 3155409
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy of broxaterol (vs salbutamol) in asthma induced by physical exercise in children].
    Corrias A; Pelosi U; Corona GB; Minelli R; Peri M; Corda R
    Pediatr Med Chir; 1989; 11(2):161-3. PubMed ID: 2569730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sulfur dioxide-induced bronchial constriction in asthmatics and its prophylaxis by salbutamol].
    Luo ZY; Zheng JP; Luo DF
    Zhonghua Nei Ke Za Zhi; 1990 Apr; 29(4):213-6, 253. PubMed ID: 2226051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broxaterol (Z.1170), a new oral beta 2-agonist compared with salbutamol.
    Perruchoud AP; Bründler H; Godly R; Imhof E; Herzog H
    Respiration; 1987; 51(2):113-8. PubMed ID: 2884706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective effect of adrenergic alpha blockaders on posthistamine bronchial spasm].
    Liebhart E; Suchnicka R; Krasnowska M
    Pneumonol Pol; 1981 Nov; 49(11):769-74. PubMed ID: 6123109
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of non-specific bronchial hyperreactivity. Dose-dependent effect of sodium cromoglycate metered dose aerosol.
    Del Bufalo D; Fasano L; Patalano F; Ruggieri F; Gunella G
    Allergol Immunopathol (Madr); 1988; 16(2):77-80. PubMed ID: 3134808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the effectiveness and tolerance of broxaterol in 10 patients with reversible bronchospasm].
    Scoditti S; Paladini A; Stomeo S; Toma P; Aversa C
    Arch Monaldi Mal Torace; 1987; 42(4):383-8. PubMed ID: 2908264
    [No Abstract]   [Full Text] [Related]  

  • 13. Salbutamol plus beclomethasone dipropionate versus theophylline for the prevention of methacholine-induced bronchospasm in patients with chronic bronchitis.
    Arossa W; Spinaci S; Testi R
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):565-8. PubMed ID: 4066080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broxaterol: a double-blind clinical trial comparing broxaterol and salbutamol.
    Rampulla C; Corsico R; Majani U; Lodola E
    Respiration; 1985; 47(4):299-302. PubMed ID: 2861630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the protective action of Salbutamol Polfa--aerosol in relation to histamine induced bronchospasm in patients with bronchial asthma, in comparison with the effect of Ventolin-Pliva, Astmopent-Polfa and Berotec-Boehringer.
    Rozniecki J; Szmidt M; Grabski W; Gondorowicz K
    Mater Med Pol; 1977; 9(4):331-5. PubMed ID: 599965
    [No Abstract]   [Full Text] [Related]  

  • 16. [Method of using salbutamol for detecting the mechanisms of bronchial patency disorders in dust-induced lung diseases].
    Zhumabekova BK
    Gig Tr Prof Zabol; 1982 Apr; (4):15-9. PubMed ID: 7084767
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of salbutamol by aerosol administration on ventilatory mechanics in asthmatic subjects].
    Brettoni B; De Paola E; Baccini A; Bruscoli G
    Minerva Med; 1976 Mar; 67(16):1027-32. PubMed ID: 1264377
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of salbutamol on post-exertion bronchial spasm and post-exertion refraction time].
    Chazan R; Droszcz W
    Pneumonol Pol; 1988 Nov; 56(11):497-500. PubMed ID: 3252189
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of interleukin-2-induced severe bronchospasm with salbutamol.
    Barutca S; Meydan N; Barlak A
    J Aerosol Med; 2003; 16(2):183-4. PubMed ID: 12823912
    [No Abstract]   [Full Text] [Related]  

  • 20. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance.
    Hargreave FE; Ryan G; Thomson NC; O'Byrne PM; Latimer K; Juniper EF; Dolovich J
    J Allergy Clin Immunol; 1981 Nov; 68(5):347-55. PubMed ID: 7028842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.